Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in type 2 diabetes patients receiving haemodialysis
ACTRN12612000352808Phase 2Recruiting
- Sponsor
- Dr Tilenka Thynne
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of metformin in type 2 diabetes mellitus (T2DM), sponsored by Dr Tilenka Thynne. Primary endpoint: Establish a safe metformin dosing regimen in haemodialysis patients based on pharmacokinetic data. Started Apr 2012; status: recruiting.
02
Drugs
metformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ACTRN12612000352808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000352808.